beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.
about
MUC1-C Oncoprotein Blocks Terminal Differentiation of Chronic Myelogenous Leukemia Cells by a ROS-Mediated MechanismWnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia developmentCancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer TreatmentSignal transduction in the chronic leukemias: implications for targeted therapiesSurvival regulation of leukemia stem cellsLSK derived LSK- cells have a high apoptotic rate related to survival regulation of hematopoietic and leukemic stem cellsKnockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C ReleaseEffect of interaction of magnetic nanoparticles of Fe₃O₄ and artesunate on apoptosis of K562 cellsLow expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia.β-catenin induces expression of prohibitin gene in acute leukemic cellsDishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma.JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo.Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival.CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cellsWnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia.NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemiaThe Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues.Cordycepin regulates GSK-3β/β-catenin signaling in human leukemia cellsBCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemiaA tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia.Role of Pten in leukemia stem cellsDifferential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice.Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy.Leukemia stem cells: the root of chronic myeloid leukemia14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia.CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamineAlternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond.The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells.Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis.Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling.FZD7 regulates BMSCs-mediated protection of CML cells.Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.Emerging therapeutic strategies for targeting chronic myeloid leukemia stem cellsTargeting survival pathways in chronic myeloid leukaemia stem cellsHydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression.PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.Mechanisms of resistance to FLT3 inhibitors.Homoharringtonine and omacetaxine for myeloid hematological malignancies.Understanding of leukemic stem cells and their clinical implications.Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity.
P2860
Q24626837-F48735D2-B888-44BF-AA12-F2A0275B6F5EQ26997109-ACDCE1DC-7B02-49F7-A001-EDC5E426D4BFQ27024816-E84EF210-0FFF-45D7-9F74-0F02141F54FEQ27026031-750E658D-BB5F-4BCC-8CEE-A5AFC03AB154Q28271278-F9E17511-100F-454F-87BA-0983B6C02E88Q28484079-125F38B0-EC27-43F7-8928-7269C3DDABF3Q28550350-062D48BF-7E1F-479C-B90C-0A96D20CB091Q28741901-D2339BF2-73A2-417C-85C8-AE75B4205C7FQ30588887-6F6AF427-3289-4BD0-9467-5B71822FD5C6Q33721147-56E38535-4C3D-43CE-9877-C51C2D00C0DCQ33889222-7F88A12C-15DA-41AA-9B0A-94F6844D5FCEQ34106870-9EAB2FA1-F0F9-4638-A5A1-89264D6FEFC5Q34117463-6A4BDAE6-A47A-4A30-ABED-BCF69C33F157Q34251497-4E840A36-CA63-4844-9114-5C6EE6B3DAC8Q34348134-73EC471C-B31F-4DAF-82C4-FD535032E31AQ34551220-45E67E6A-0D83-4FF5-B81A-8AC6B42AB1E8Q34750582-F6071725-6B32-4DAE-97C2-C0C167A8D004Q35006305-CB411616-C992-4BE2-846D-0E9FF7466EEEQ35067505-353FB5C5-8929-41B9-98AF-65B4CFA0794DQ35112252-19E5E9A8-8AA3-44F5-8FEE-B182E5CC6B63Q35169570-800F03E1-AF23-4762-B164-C084289568F0Q35613150-4D84F2C7-C5B1-4BC4-A35F-B4AA839A563DQ35640320-476AE620-8D75-489C-AFF1-1F2EB270A413Q35650523-4B0CB61C-3107-4DA8-AF83-4CDDF1A4FC69Q35683215-04B155E4-6A9E-461E-B94B-B148A775FCDFQ35865075-142EA835-C6A8-453F-BC48-673941109E27Q35931271-812431FC-0909-45C3-8842-35110CADE165Q36129530-475E3896-7C04-4E1B-BEBD-7A47174DF167Q36386263-9A7125F7-1430-4137-8D00-04FB01B4F1E3Q36666798-E26E90EC-D87F-4C31-BDBA-200B9E07EDFCQ36905871-F105C074-0FD7-4359-91E3-546DA64E60E8Q36987654-5177AAF5-EB69-4208-8839-463910281D95Q37051682-4EE942BB-D7DB-4265-9E9C-B951D2A603ACQ37122686-BC8E9CD3-F3B6-4CFB-BE26-206AC0B5B723Q37161280-ED15B1F0-82AF-4AB9-B481-7FBA80436B52Q37200863-3294E5F0-6FCC-4413-A2AB-E3324FBA3F5CQ37375423-F49F5EE1-E6E9-42C9-8EB3-DB9E52111170Q37446279-CA30DCB5-1BAF-46C5-A2CF-6ECC230287FEQ37616010-634E2A1D-A494-4467-9F59-28BEDA326668Q37683837-3517920F-CF98-4424-8538-37FC1B4B5EFC
P2860
beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
beta-Catenin is essential for ...... uced chronic myeloid leukemia.
@en
beta-Catenin is essential for ...... uced chronic myeloid leukemia.
@nl
type
label
beta-Catenin is essential for ...... uced chronic myeloid leukemia.
@en
beta-Catenin is essential for ...... uced chronic myeloid leukemia.
@nl
prefLabel
beta-Catenin is essential for ...... uced chronic myeloid leukemia.
@en
beta-Catenin is essential for ...... uced chronic myeloid leukemia.
@nl
P2093
P356
P1433
P1476
beta-Catenin is essential for ...... uced chronic myeloid leukemia.
@en
P2093
P2888
P304
P356
10.1038/LEU.2008.262
P577
2008-09-25T00:00:00Z